A 38-year-old woman with chronic low back pain is treated with gabapentin, which modulates pain by blocking voltage-gated calcium channels. Which feature best distinguishes the analgesic mechanism of gabapentin from that of opioid receptor agonists like morphine?

Explanation

## Gabapentin vs Opioid Analgesia: Mechanism Comparison ### Site of Action: The Key Discriminator | Aspect | Gabapentin | Morphine (Opioids) | |--------|---|---| | **Primary Site** | Presynaptic voltage-gated Ca²⁺ channels (α~2~δ subunit) | Postsynaptic opioid receptors (μ, δ, κ) | | **Action** | Reduces Ca²⁺ influx → ↓ neurotransmitter release | Activates G-protein coupled receptors → ↑ K⁺ efflux, ↓ cAMP | | **Neurotransmitter Effect** | Decreases glutamate, GABA, noradrenaline release | Inhibits pain neurotransmitter release (substance P, glutamate) | | **Receptor Specificity** | Non-selective (affects multiple neurotransmitter systems) | Highly selective (opioid receptor subtypes) | | **Tolerance Development** | Minimal | Significant (chronic use) | | **Respiratory Depression** | None | Significant | **Key Point:** Gabapentin acts **presynaptically** on voltage-gated calcium channels in the terminal of pain-transmitting neurons, reducing neurotransmitter release. Morphine acts **postsynaptically** on opioid receptors on pain-modulating neurons, hyperpolarizing them and reducing pain signal transmission. ### Mechanism Flowchart ```mermaid flowchart TD A[Nociceptive Input]:::outcome --> B[Dorsal Horn Synapse] B --> C{Gabapentin}:::decision B --> D{Morphine}:::decision C -->|Blocks presynaptic Ca²⁺ channels| E[↓ Glutamate/SP release]:::action D -->|Activates postsynaptic μ-receptors| F[↑ K⁺ efflux, hyperpolarization]:::action E --> G[Reduced pain signal]:::outcome F --> G ``` ### Clinical Correlations **Clinical Pearl:** Gabapentin is particularly effective for neuropathic pain (diabetic neuropathy, postherpetic neuralgia) because it reduces aberrant neurotransmitter release in damaged nerves. Morphine is better for acute somatic/visceral pain because it activates descending inhibitory pathways. **High-Yield:** Gabapentin does NOT cause respiratory depression or significant tolerance, making it safer for long-term use in chronic pain. Opioids carry risks of respiratory depression, addiction, and tolerance. **Mnemonic:** **GABA-PRESYN** — Gabapentin acts at the PREsynaptic terminal; **OPIOID-POSTSYN** — Opioids act at the POSTsynaptic membrane. ### Why Other Options Are Incorrect - **Neurotransmitter system targeted:** Both drugs ultimately modulate inhibitory pain pathways, but this is not the PRIMARY discriminator of their mechanisms. - **Spinal cord laminae:** Both affect laminae I & II (substantia gelatinosa), the main pain relay station. - **Fiber type modulation:** Both affect C fibers primarily, though gabapentin also modulates A-delta fibers via different mechanisms. [cite:KD Tripathi Essentials of Medical Pharmacology 8e Ch 12]